ArticleiLIVER2025

Recalibrating the evidence level in hepatocellular carcinoma: Integrating efficacy and effectiveness of immunotherapy.

Han Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.